These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26848142)

  • 1. Dual time-point (18)F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases.
    Lafuente S; Fuster D; Arguis P; Granados U; Perlaza P; Paredes P; Vollmer I; Sánchez M; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):226-31. PubMed ID: 26848142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.
    Okuma T; Okamura T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Koyama K; Inoue K; Nakamura K; Inoue Y
    Ann Nucl Med; 2006 Feb; 20(2):115-21. PubMed ID: 16615420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
    Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M
    J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
    Chen S; Li X; Chen M; Yin Y; Li N; Li Y
    Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
    Alafate A; Shinya T; Okumura Y; Sato S; Hiraki T; Ishii H; Gobara H; Kato K; Fujiwara T; Miyoshi S; Kaji M; Kanazawa S
    Acta Med Okayama; 2013; 67(2):105-12. PubMed ID: 23603927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors.
    Sharma A; Lanuti M; He W; Palmer EL; Shepard JA; Digumarthy SR
    J Comput Assist Tomogr; 2013; 37(1):9-14. PubMed ID: 23321827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study.
    Bonichon F; Palussière J; Godbert Y; Pulido M; Descat E; Devillers A; Meunier C; Leboulleux S; de Baère T; Galy-Lacour C; Lagoarde-Segot L; Cazeau AL
    Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1817-27. PubMed ID: 24042540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of dual-time
    Pahk K; Chung JH; Kim S; Lee SH
    Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of local tumor progression by (18)F-FDG PET/CT following lung radiofrequency ablation: PET versus CT.
    Suzawa N; Yamakado K; Takao M; Taguchi O; Yamada T; Takeda K
    Clin Nucl Med; 2013 Apr; 38(4):e166-70. PubMed ID: 23429399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
    Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
    Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation.
    Deandreis D; Leboulleux S; Dromain C; Auperin A; Coulot J; Lumbroso J; Deschamps F; Rao P; Schlumberger M; de Baère T
    Radiology; 2011 Jan; 258(1):270-6. PubMed ID: 21045185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?
    Yoo DC; Dupuy DE; Hillman SL; Fernando HC; Rilling WS; Shepard JA; Siegel BA
    AJR Am J Roentgenol; 2011 Aug; 197(2):334-40. PubMed ID: 21785078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous radiofrequency ablation of lung metastases from colorectal carcinoma under C-arm cone beam CT guidance.
    Amouyal G; Pernot S; Déan C; Cholley B; Scotté F; Sapoval M; Pellerin O
    Diagn Interv Imaging; 2017 Nov; 98(11):793-799. PubMed ID: 28571704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic yield of baseline and follow-up PET/CT studies in ablative therapy for non-small cell lung cancer.
    Pou Ucha JL; Nogueiras Alonso JM; Alvarez Paez AM; Suarez Arfenoni BA; Puig AS; Lopez Lopez AM; Barandela Salgado J; Campos Villarino LM; Casal Rivas M; Guitian Iglesias R
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):301-7. PubMed ID: 23084012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorodeoxyglucose positron emission tomography for detection of tumor recurrence following radiofrequency ablation in retrospective cohort of stage I lung cancer.
    Wang Y; Lanuti M; Bernheim A; Shepard JO; Sharma A
    Int J Hyperthermia; 2018; 35(1):1-8. PubMed ID: 29719997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET.
    Higuchi M; Honjo H; Shigihara T; Shishido F; Suzuki H; Gotoh M
    J Cancer Res Clin Oncol; 2014 Nov; 140(11):1957-63. PubMed ID: 24952227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful?
    Liu ZY; Chang ZH; Lu ZM; Guo QY
    Chin Med J (Engl); 2010 Jul; 123(13):1690-4. PubMed ID: 20819630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-session radiofrequency ablation of bilateral lung metastases.
    Palussière J; Gómez F; Cannella M; Ferron S; Descat E; Fonck M; Brouste V; Avril A
    Cardiovasc Intervent Radiol; 2012 Aug; 35(4):852-9. PubMed ID: 21647807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.